Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Payables: 2019-2025

Historic Payables for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $8.6 million.

  • CureVac N.V's Payables rose 6.07% to $8.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $51.7 million, marking a year-over-year decrease of 44.72%. This contributed to the annual value of $18.5 million for FY2024, which is 64.29% down from last year.
  • Latest data reveals that CureVac N.V reported Payables of $8.6 million as of Q2 2025, which was down 13.47% from $9.9 million recorded in Q1 2025.
  • CureVac N.V's 5-year Payables high stood at $146.1 million for Q4 2021, and its period low was $8.1 million during Q2 2024.
  • Its 3-year average for Payables is $17.6 million, with a median of $14.7 million in 2023.
  • Its Payables has fluctuated over the past 5 years, first spiked by 121,071.74% in 2021, then plummeted by 77.42% in 2023.
  • CureVac N.V's Payables (Quarterly) stood at $146.1 million in 2021, then tumbled by 48.70% to $75.0 million in 2022, then slumped by 31.05% to $51.7 million in 2023, then slumped by 64.29% to $18.5 million in 2024, then increased by 6.07% to $8.6 million in 2025.
  • Its Payables stands at $8.6 million for Q2 2025, versus $9.9 million for Q1 2025 and $18.5 million for Q4 2024.